T H 2 and T H 17 inflammatory pathways are reciprocally regulated in asthma
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Increasing evidence suggests that asthma is a heterogeneous disorder regulated by distinct molecular mechanisms. In a cross-sectional study of asthmatics of varying severity (n = 51), endobronchial tissue gene expression analysis revealed three major patient clusters: TH2-high, TH17-high, and TH2/17-low. TH2-high and TH17-high patterns were mutually exclusive in individual patient samples, and their gene signatures were inversely correlated and differentially regulated by interleukin-13 (IL-13) and IL-17A. To understand this dichotomous pattern of T helper 2 (TH2) and TH17 signatures, we investigated the potential of type 2 cytokine suppression in promoting TH17 responses in a preclinical model of allergen-induced asthma. Neutralization of IL-4 and/or IL-13 resulted in increased TH17 cells and neutrophilic inflammation in the lung. However, neutralization of IL-13 and IL-17 protected mice from eosinophilia, mucus hyperplasia, and airway hyperreactivity and abolished the neutrophilic inflammation, suggesting that combination therapies targeting both pathways may maximize therapeutic efficacy across a patient population comprising both TH2 and TH17 endotypes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The data summarized above suggest that targeting JAK and STAT3 with small-molecule inhibitors may provide a superior anti-asthma treatment approach compared with standard therapies as, they would target both Th2- and Th17-associated asthmas (Choy et al., 2015).”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Choy et al., 2015
In the citing paper
“almost all murine models of intestinal fibrosis are influenced by the microbiota154”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [154]
Citations
Cites
The global burden of asthma: executive summary of the GINA Dissemination Committee Report
Masoli, M., Fabian, D., Holt, S., Beasley, R., & Program, G. I. F. A. (. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00526.x · Cited by 3,529
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Castro, M., Curran-Everett, D., Fitzpatrick, A. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0896oc · Cited by 2,129
British Guideline on the Management of Asthma
British Thoracic Society Scottish Intercollegiate Guidelines Network (2008) · Thorax · doi:10.1136/thx.2008.097741 · Cited by 2,021
Cluster analysis and clinical asthma phenotypes
Haldar, P., Pavord, I. D., Shaw, D. E., Berry, M. A., Thomas, M., Brightling, C. E., Wardlaw, A. J., & Green, R. H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1754oc · Cited by 1,987
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., Marshall, R. P., Bradding, P., Green, R. H., Wardlaw, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808991 · Cited by 1,871 · cited 1×
“Identifying the molecular mechanisms driving subtypes of asthma has the potential to reveal drug targets, biomarkers to predict treatment response, and appropriately target therapy, as evidenced by recent clinical studies of T helper 2 (TH2) cytokine antagonists (8, 9).”
BackgroundSelf-citationThe development of allergic inflammation
Galli, S. J., Tsai, M., & Piliponsky, A. M. (2008) · Nature · doi:10.1038/nature07204 · Cited by 1,839
T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Arron, J. R., Koth, L. L., & Fahy, J. V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0392oc · Cited by 1,803 · cited 6×
“SERPINB2, CLCA1, and POSTN were used as IL-13–responsive TH2 signature genes as described previously (25, 26).”
BackgroundMethodInfluentialSelf-citationAsthma exacerbations and sputum eosinophil counts: a randomised controlled trial
Green, R. H., Brightling, C. E., McKenna, S., Hargadon, B., Parker, D., Bradding, P., Wardlaw, A. J., & Pavord, I. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11679-5 · Cited by 1,755
Self-citationLebrikizumab Treatment in Adults with Asthma
Corren, J., Lemanske, R. F., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106469 · Cited by 1,514
Self-citationTargeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
Cited by
Items 101–200 of 458
New Perspectives in the Diagnosis and Management of Allergic Fungal Airway Disease
Wardlaw, A. J., Rick, E., Özyiğit, L. P., Scadding, A., Gaillard, E. A., & Pashley, C. H. (2021) · Journal of Asthma and Allergy · doi:10.2147/jaa.s251709 · Cited by 71
Wan, X. C., & Woodruff, P. G. (2016) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2016.03.004 · Cited by 75
Eosinophilic Endotype of Asthma
Alemán, F., Lim, H. F., & Nair, P. K. (2016) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2016.03.006 · Cited by 67
The Protective Effects of Helicobacter pylori Infection on Allergic Asthma
Zuo, Z. T., Ma, Y., Sun, Y., Bai, C., Ling, C.-H., & Yuan, F. L. (2020) · International Archives of Allergy and Immunology · doi:10.1159/000508330 · Cited by 70
The immunology of asthma and chronic rhinosinusitis
Kato, A., & Kita, H. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01159-0 · Cited by 76
Angkasekwinai, P. (2019) · Current Allergy and Asthma Reports · doi:10.1007/s11882-019-0860-8 · Cited by 65
Safranal Alleviated OVA-Induced Asthma Model and Inhibits Mast Cell Activation
Lertnimitphun, P., Zhang, W., Fu, W., Yang, B., Zheng, C., Yuan, M., Zhou, H., Zhang, X., Pei, W., Lu, Y., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.585595 · Cited by 63
“Another approach for the treatment of asthma is keeping a balance of Th2 cytokines (33).”
BackgroundRaftis, E. J., Delday, M. I., Cowie, P., McCluskey, S. M., Singh, M. D., Ettorre, A., & Mulder, I. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-30448-z · Cited by 65
Updates on T helper type 17 immunity in respiratory disease
Iwanaga, N., & Kolls, J. K. (2018) · Immunology · doi:10.1111/imm.13006 · Cited by 63
Cross-talk between TH2 and TH17 pathways in patients with chronic rhinosinusitis with nasal polyps
Wang, M., Zhang, N., Zheng, M., Li, Y., Meng, L., Ruan, Y., Han, J., Zhao, N., Wang, X., Zhang, L., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.06.023 · Cited by 61
“neutrophil numbers in TH17 inflammation, as has been assumed in a study using a mouse model of allergen-induced asthma.(6) Complex regulation of the TH2 and TH17 pathways in patients with CRSwNP also has important implications for CRSwNP treatments.”
BackgroundTargeting IL-17A/glucocorticoid synergy to CSF3 expression in neutrophilic airway diseases
Ouyang, S., Liu, C., Xiao, J., Chen, X., Lui, A. C., & Li, X. (2020) · JCI Insight · doi:10.1172/jci.insight.132836 · Cited by 63
Role of IL‐17 in atopy—A systematic review
Hofmann, M. A., Fluhr, J. W., Ruwwe‐Glösenkamp, C., Stevanovic, K., Bergmann, K., & Zuberbier, T. (2021) · Clinical and Translational Allergy · doi:10.1002/clt2.12047 · Cited by 63
“In a mouse‐model, Choy et al.39 showed that the simultaneous neutralization of IL‐13 and IL‐17 protected mice from eosinophilia, mucus hyperplasia and airway hyperreac- tivity, and subsequently abolished the neutrophilic inflammation in asthma.”
Airway and serum biochemical correlates of refractory neutrophilic asthma
Alam, R., Good, J. T., Rollins, D. R., Verma, M., Chu, H., Pham, T., & Martin, R. J. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.12.963 · Cited by 63
The Th1/Th17 balance dictates the fibrosis response in murine radiation-induced lung disease
Paun, A., Bergeron, M.-E., & Haston, C. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-11656-5 · Cited by 59
Li, R., Wang, J., Zhu, F., Li, R., Liu, B., Xu, W., He, G., Cao, H., Wang, Y., & Yang, J. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.02.014 · Cited by 60
“A Th2 response is characteristic of allergic eosinophilic asthma, whereas Th17 cells contribute to severe and fatal asthma exacerbations and steroid therapy resistance (Choy et al., 2015; Zhao et al., 2013; Cosmi et al., 2011).”
BackgroundThe airway epithelium in asthma
Bonser, L. R., & Erle, D. J. (2019) · Advances in immunology · doi:10.1016/bs.ai.2019.05.001 · Cited by 60
Pollutants, microbiota and immune system: frenemies within the gut
Rio, P., Gasbarrini, A., Gambassi, G., & Cianci, R. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1285186 · Cited by 62
Enhanced protection from fibrosis and inflammation in the combined absence of IL‐13 and IFN‐γ
Ramalingam, T. R., Gieseck, R. L., Acciani, T. H., M Hart, K., Cheever, A. W., Mentink‐Kane, M. M., Vannella, K. M., & Wynn, T. A. (2016) · The Journal of Pathology · doi:10.1002/path.4733 · Cited by 55
“Type 2 cytokine responses, defined by the cytokines interleukin-4 (IL-4), IL-5, IL-9, and IL-13, and type 1 responses characterized by IL-12 and IFN-γ [1] play distinct roles in immunity, inflammation, and fibrosis, and both responses undergo significant cross-regulation or suppression by the opposing pathway [2,3].”
BackgroundResultSelf-citationIftikhar, I. H., Schimmel, M., Bender, W., Swenson, C., & Amrol, D. J. (2018) · Lung · doi:10.1007/s00408-018-0151-5 · Cited by 58
Immunopathology alters Th17 cell glucocorticoid sensitivity
Banuelos, J., Cao, Y., Shin, S. C., & Lu, N. Z. (2016) · Allergy · doi:10.1111/all.13051 · Cited by 58
dos Santos, T. M., Righetti, R. F., Camargo, L. D. N., Saraiva-Romanholo, B. M., Aristóteles, L. R. C. R. B., de Souza, F. C. R., Fukuzaki, S., Alonso‐Vale, M. I. C., Cruz, M. M., Prado, C. M., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01183 · Cited by 56
“This cytokine stimulates a Th2 cell response, airway hyper-reactivity, neutrophil infiltration, and mucus production (Doe et al., 2010; Choy et al., 2015; Chenuet et al., 2017).”
BackgroundBranchett, W. J., Stölting, H., Oliver, R. A., Walker, S. A., Puttur, F. K., Gregory, L. G., Gabryšová, L., Wilson, M. S., O’Garra, A., & Lloyd, C. M. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.08.006 · Cited by 56
Nazimek, K., Bryniarski, K., & Askenase, P. W. (2016) · International Archives of Allergy and Immunology · doi:10.1159/000449249 · Cited by 60
Lv, J., Xiong, Y., Li, W., Cui, X., Cheng, X., Leng, Q., & He, R. (2018) · Allergy · doi:10.1111/all.13395 · Cited by 57
The Role of T Cells and Macrophages in Asthma Pathogenesis: A New Perspective on Mutual Crosstalk
Zhu, X., Cui, J., Yi, L., Qin, J., Wuniqiemu, T., Teng, F., Tang, W., Wei, Y., & Dong, J. (2020) · Mediators of Inflammation · doi:10.1155/2020/7835284 · Cited by 61
“The Th17/Treg imbalance mechanism, which leads to neutrophilic, severe, or corticosteroid-resistant asthma, is a supplement to the Th1/Th2 imbalance mechanism in asthma [35, 36].”
BackgroundManni, M. L., Mandalapu, S., McHugh, K. J., Elloso, M. M., Dudas, P. L., & Alcorn, J. F. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501531 · Cited by 54
“vestigate the molecular pathways underlying “high” Th2/Th17 disease (55).”
BackgroundValladao, A. C., Frevert, C. W., Koch, L., Campbell, D., & Ziegler, S. F. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600007 · Cited by 60
“velopment of a Th17 allergic phenotype after blockade of Th2 cytokines (23, 31).”
BackgroundBui, T. T., Piao, C. H., Song, C. H., Lee, C.-H., Shin, H. S., & Chai, O. H. (2017) · Anatomy & Cell Biology · doi:10.5115/acb.2017.50.2.124 · Cited by 55
“Airway inflammation in asthma is associated with T-cell immune response in which Th2 cell derived cytokines including IL-1β, IL-4, IL-5, and TNF-α are thought to contribute to eosinophil recruitment, mucus hypersecretion, and airway hyperresponsiveness [3-5] by controlling the key process of IgE production, the growth…”
BackgroundTranscriptomic Profiles in Nasal Epithelium and Asthma Endotypes in Youth
Yue, M., Gaietto, K. M., Han, Y. Y., Rosser, F. J., Xu, Z., Qoyawayma, C., Acosta‐Pérez, E., CANINO, G. J., Forno, E., Chen, W., et al. (2025) · JAMA · doi:10.1001/jama.2024.22684 · Cited by 56
Kim, S., Hong, J.-H., Lee, J., & Lee, Y. (2017) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2017.03.011 · Cited by 53
IL33 contributes to diesel pollution‐mediated increase in experimental asthma severity
Brandt, E. B., Bolcas, P. E., Ruff, B. P., & Hershey, G. K. K. (2020) · Allergy · doi:10.1111/all.14181 · Cited by 55
Ajendra, J., Chenery, A. L., Parkinson, J. E., Chan, B. H. K., Pearson, S., Colombo, S. A. P., Boon, L., Grencis, R. K., Sutherland, T. E., & Allen, J. E. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0318-2 · Cited by 54
“The detrimental relationship between IL-17A and type 2 associated diseases has also been extensively documented in allergic asthma in which the most severe symptoms occur in patients with both high Th2 and Th17 cell responses [7].”
BackgroundMechanisms regulating neutrophil responses in immunity, allergy, and autoimmunity
Özcan, A., & Boyman, O. (2022) · Allergy · doi:10.1111/all.15505 · Cited by 54
Na, H., Lim, H., Choi, G., Kim, B., Kim, S., Chang, Y., Nurieva, R., Dong, C., Chang, S. H., & Chung, Y. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.07.050 · Cited by 54
“However, blocking either the TH2 or TH17 pathway with anti–IL-13 or anti–IL-17 alone has been shown not to be sufficient for the treatment of allergic asthma because such treatment resulted in upregulation of the other pathway.(18) Similarly, a recent study by Park et al(34) demonstrated that coadministration of anti–…”
ResultPredictors of Asthma/COPD Overlap in FDNY Firefighters With World Trade Center Dust Exposure
Singh, A., Liu, C., Putman, B., Zeig‐Owens, R., Hall, C. B., Schwartz, T. M., Webber, M. P., Cohen, H. W., Berger, K. I., Nolan, A., et al. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.07.002 · Cited by 55
New concepts in asthma: clinical phenotypes and pathophysiological mechanisms
Koczulla, A. R., Vogelmeier, C. F., Garn, H., & Renz, H. E. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.11.008 · Cited by 55
Evans, M. D., Esnault, S. J., Denlinger, L. C., & Jarjour, N. N. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.09.035 · Cited by 55
“Age (y) 28 (21-45) Sex 21 F, 27 M Race 38 C, 6 AA, 2 H, 1 AsA, 1 NtA BMI (kg/m(2)) 27 (25-32) Asthma severity 31 Nonsevere, 17 severe ICS dose 14 None, 6 low, 10 medium, 17 high Oral corticosteroid 1 Patient with severe asthma Total IgE (IU/mL) 125 (44-296) Positive skin prick test response 90% (43/48) FEV1 PP 81 (66-…”
Pharmacological Rationale for Targeting IL-17 in Asthma
Rahmawati, S. F., Velde, M. T., Kerstjens, H. A. M., Dömling, A. S. S., Groves, M. R., & Gosens, R. (2021) · Frontiers in Allergy · doi:10.3389/falgy.2021.694514 · Cited by 54
“Interleukin−17A has been shown to moderately suppress several IL-13 inducible genes (POSTN, CLCA1, SERPINB2) in human bronchial epithelial cells (7).”
BackgroundInfluentialChen, S., Yao, L., Huang, P., He, Q., Guan, H., Luo, Y., Zou, Z., Wei, S., Peng, G., Yan, J., et al. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz099 · Cited by 54
Considering biomarkers in asthma disease severity
Čustović, A., Siddiqui, S., & Saglani, S. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.11.021 · Cited by 50
Self-citationInfluence of the early-life gut microbiota on the immune responses to an inhaled allergen
Borbet, T. C., Pawline, M. B., Zhang, X., Wipperman, M. F., Reuter, S., Maher, T., Li, J., Iizumi, T., Gao, Z., Daniele, M., et al. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00544-5 · Cited by 52
Troy, N. M., Hollams, E. M., Holt, P. G., & Bosco, A. (2016) · BMC Medical Genomics · doi:10.1186/s12920-016-0171-z · Cited by 53
“Finally, the differential network analyses we performed require group-wise comparisons, and this is a limitation because asthma is a heterogeneous disease that comprises multiple subphenotypes [3].”
Chen, R., Zhang, Q., Chen, S., Tang, H., Huang, P., Wei, S., Liang, Z., Chen, X., Tao, A., & Yao, L. (2019) · European Respiratory Journal · doi:10.1183/13993003.01510-2018 · Cited by 49
Promises and challenges of biologics for severe asthma
Tan, R., Liew, M. F., Lim, H. F., Leung, B. P. L., & Wong, W. S. F. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114012 · Cited by 51
Alobaidi, A. H., Alsamarai, A. M., & Alsamarai, M. A. (2021) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523020666210920100707 · Cited by 49
Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?
Varricchi, G., Senna, G., Loffredo, S., Bagnasco, D., Ferrando, M., & Canonica, G. W. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00242 · Cited by 49
“By contrast, “Th2-low” asthma is less well characterized and probably represents a mix of multiple endotypes involving subgroups of patients (1, 17, 18).”
BackgroundThe “one airway, one disease” concept in light of Th2 inflammation
Giovannini‐Chami, L., Paquet, A. C., Sanfiorenzo, C., Pons, N., Cazareth, J., Magnone, V., Lebrigand, K., Chevalier, B., Vallauri, A., Julia, V., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00437-2018 · Cited by 52
IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosis
Birnhuber, A., Crnković, S., Biasin, V., Marsh, L. M., Odler, B., Sahu-Osen, A., Stacher‐Priehse, E., Brčić, L., Schneider, F., Čikeš, N., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00154-2019 · Cited by 47
From Infections to Anthropogenic Inflicted Pathologies: Involvement of Immune Balance
Lee, F., & Lawrence, D. A. (2017) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2017.1412212 · Cited by 46
“Choy et al. (2015) indicated that different levels of Th2 and Th17 pathways influence asthmatic patients suggesting that both pathways need to be targeted for therapeutic intervention.”
BackgroundA Distinct Inhibitory Function for miR-18a in Th17 Cell Differentiation
Montoya, M. M., Maul, J., Singh, P. B., Pua, H. H., Dahlström, F., Wu, N., Huang, X., Ansel, K. M., & Baumjohann, D. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700170 · Cited by 50
“dicate that lung inflammation can shift to a response marked by Th17 cytokines and neutrophil infiltration when Th2 cell–mediated eosinophilia is reduced (6, 7).”
BackgroundEmson, C. L., Diver, S. E., Chachi, L., Megally, A., Small, C. L., Downie, J., Parnes, J. R., Bowen, K., Colice, G., & Brightling, C. E. (2020) · Respiratory Research · doi:10.1186/s12931-020-01513-x · Cited by 46
“This marker has been proposed to correlate with FeNO, blood eosinophils and airway hyperresponsiveness [23], and with clinical markers of T2 inflammation in patients with mild through to severe asthma [50].”
BackgroundDjukanović, R., Adcock, I. M., Anderson, G. P., Bel, E. H., Canonica, G. W., Cao, H., Chung, K. F., Davies, D. E., Genton, C., Gibson-Latimer, T., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.01671-2018 · Cited by 46
New and emerging drug treatments for severe asthma
Diver, S. E., RUSSELL, R. J., & Brightling, C. E. (2018) · Clinical & Experimental Allergy · doi:10.1111/cea.13086 · Cited by 46
“proportion of T2 low disease may be iatrogenic.(29) Some patients”
BackgroundGlucocortiosteroid subsensitivity and asthma severity
Mukherjee, M., Svenningsen, S., & Nair, P. K. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000337 · Cited by 45
Siddiqui, S., Denlinger, L. C., Fowler, S. J., Akuthota, P., Shaw, D. E., Heaney, L. G., Brown, L. C., Castro, M., Winders, T. A., Kraft, M., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201809-1817pp · Cited by 44
Self-citationSerum oxidative stress parameters of women with hypothyroidism.
Coria, M. J., Pastrán, A. I., & Giménez, M. S. (2009) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 53
Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies
Geng, B., Bachert, C., Busse, W. W., Gevaert, P., Lee, S. E., Niederman, M. S., Chen, Z., Lu, X., Khokhar, F. A., Kapoor, U., et al. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.12.006 · Cited by 43
Which Therapy for Non-Type(T)2/T2-Low Asthma
Ricciardolo, F. L. M., Carriero, V. M. A., & Bertolini, F. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm12010010 · Cited by 47
“, reporting that Th17 response can be promoted by suppressing the T2 pathway, suggest that a double blockade of T2 and T3 processes may be beneficial in asthma [38].”
BackgroundTowards Targeting the Aryl Hydrocarbon Receptor in Cystic Fibrosis
Puccetti, M., Paolicelli, G., Oikonomou, V., LUCA, A. D., Renga, G., Borghi, M., Pariano, M., Stincardini, C., Scaringi, L., Giovagnoli, S., et al. (2018) · Mediators of Inflammation · doi:10.1155/2018/1601486 · Cited by 43
Khalfaoui, L., Symon, F. A., Couillard, S., Hargadon, B., Chaudhuri, R., Bicknell, S., Mansur, A. H., Shrimanker, R., Hinks, T., Pavord, I. D., et al. (2022) · Allergy · doi:10.1111/all.15376 · Cited by 41
Self-citationDiver, S. E., Haldar, K., McDowell, P. J., Busby, J., Mistry, V., Micieli, C., Brown, V., Cox, C., Yang, F., Borg, C. A., et al. (2022) · Allergy · doi:10.1111/all.15425 · Cited by 41
Self-citationLeonardi, A., Daull, P., Garrigue, J., Cavarzeran, F., Docquier, M., Stefano, A. D., Tarricone, E., & Brun, P. (2020) · The Ocular Surface · doi:10.1016/j.jtos.2020.09.009 · Cited by 40
Korn, A., Miller, D., Dong, L., Buckles, E. L., Wagner, B., & Ainsworth, D. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142622 · Cited by 38
“They found that gene signature profiles of Th2 (IL-13, IL-4) and Th17 (CXCL1, CXCL2, CXCL3, IL-8, CSF3) immune responses were inversely correlated in these samples suggesting a reciprocal regulation of these two pathways in asthma [41].”
Park, S. C., Kim, H., Bak, Y., Shim, D., Kwon, K. W., Kim, C., Yoon, J., & Shin, S. J. (2020) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2020.12.3.537 · Cited by 38
New Insights into Asthma Inflammation: Focus on iNKT, MAIT, and γδT Cells
Victor, J. R., Lezmi, G., & Leite‐de‐Moraes, M. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08784-8 · Cited by 41
Siddiqui, S., Shikotra, A., Richardson, M., Doran, E., Choy, D. F., Bell, A. G., Austin, C. D., Eastham‐Anderson, J., Hargadon, B., Arron, J. R., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.12.982 · Cited by 38
Self-citationCharacterization and pro‐inflammatory potential of indoor mold particles
Holme, J. A., Øya, E., Afanou, A. K., Øvrevik, J., & Eduard, W. (2020) · Indoor Air · doi:10.1111/ina.12656 · Cited by 41
“Human with asthma have various distinct phenotypes, including differential expressions of TH2 and TH17 signatures (242, 243).”
BackgroundTNFα and IL-17 alkalinize airway surface liquid through CFTR and pendrin
Rehman, T., Thornell, I. M., Pezzulo, A. A., Thurman, A. L., Ibarra, G. S. R., Karp, P. H., Tan, P., Duffey, M. E., & Welsh, M. J. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00112.2020 · Cited by 38
Hu, Y., Chen, Z., Zeng, J., Zheng, S., Sun, L., Zhu, L., & Liao, W. (2020) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-020-00457-7 · Cited by 37
The Role of the Cutaneous Mycobiome in Atopic Dermatitis
Szczepańska, M., Blicharz, L., Nowaczyk, J., Makowska, K., Goldust, M., Waśkiel‐Burnat, A., Czuwara, J., Samochocki, Z., & Rudnicka, L. (2022) · Journal of Fungi · doi:10.3390/jof8111153 · Cited by 40
Staton, T. L., Peng, K., Owen, R., Choy, D. F., Cabanski, C. R., Fong, A., Brunstein, F., Alatsis, K. R., & Chen, H. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0763-9 · Cited by 37
Self-citationGo With Your Gut: The Shaping of T-Cell Response by Gut Microbiota in Allergic Asthma
Gangi, A. D., Cicco, M. D., Comberiati, P., & Peroni, D. G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01485 · Cited by 38
“Furthermore, the role of Th17 in AAS was heavily investigated (9) and they are currently recognized as one of the crucial mediators of AAS.”
BackgroundCharacteristics and Role of Neutrophil Extracellular Traps in Asthma
Chen, F., Yu, M. H., Zhong, Y., Wang, L., & Huang, H. (2021) · Inflammation · doi:10.1007/s10753-021-01526-8 · Cited by 39
“Previous studies have shown that asthma is mainly driven by Th2 cells secreting IL-4, IL-5, and IL-13, leading to airway eosinophil inflammation [62].”
BackgroundPathogenesis of Children’s Allergic Diseases: Refocusing the Role of the Gut Microbiota
Hu, T., Dong, Y., Yang, C., Zhao, M., & He, Q. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.749544 · Cited by 39
CCR9 Is a Key Regulator of Early Phases of Allergic Airway Inflammation
López-Pacheco, C. P., Soldevila, G., Pont, G. D., Hernández‐Pando, R., & García-Zepeda, E. A. (2016) · Mediators of Inflammation · doi:10.1155/2016/3635809 · Cited by 36
“An increase in IL-17 expression is related to neutrophilic inflammation that is also associated with an increase in the levels of certain CXC chemokines and mucin hyperplasia [60, 61].”
Huang, C., Wang, C., Fu, C., Huang, C., Chang, P., Chen, Y.-W., Wu, C., Wu, P., & Lee, T. (2016) · Medicine · doi:10.1097/md.0000000000005432 · Cited by 36
Systems biology and big data in asthma and allergy: recent discoveries and emerging challenges
Tang, H. H. F., Sly, P. D., Holt, P. G., Holt, K. E., & Inouye, M. (2019) · European Respiratory Journal · doi:10.1183/13993003.00844-2019 · Cited by 37
Identification of cough-variant asthma phenotypes based on clinical and pathophysiologic data
Zhan, W., Wu, F., Zhang, Y., Lin, L., Li, W., Luo, W., Yi, F., Dai, Y., Li, S., Lin, J., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.04.017 · Cited by 37
Shikotra, A., Choy, D. F., Siddiqui, S., Arthur, G. K., Nagarkar, D. R., Jia, G., Wright, A. K. A., Ohri, C. M., Doran, E., Butler, C. A., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600606 · Cited by 36
“For example, we have shown that within an asthma cohort, three molecular clusters based on gene expression signatures for IL-4/13 (Th2) and IL-17A (Th17) were present: Th2-high, Th17-high, and Th17-low (10).”
BackgroundMethodResultSelf-citationLung clearance index: assessment and utility in children with asthma
Nuttall, A., Velásquez, W., Beardsmore, C., & Gaillard, E. A. (2019) · European Respiratory Review · doi:10.1183/16000617.0046-2019 · Cited by 35
Chlorogenic acid ameliorated allergic rhinitis-related symptoms in mice by regulating Th17 cells
Shi, Z., Jiang, W., Chen, X., Xu, M., Wang, J., Lai, Y., & Zha, D. (2020) · Bioscience Reports · doi:10.1042/bsr20201643 · Cited by 35
Elucidating novel disease mechanisms in severe asthma
Kim, R., Rae, B., Neal, R., Donovan, C., Pinkerton, J., Balachandran, L., Starkey, M. R., Knight, D. A., Horvat, J. C., & Hansbro, P. M. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.37 · Cited by 36
Atopic asthmatic immune phenotypes associated with airway microbiota and airway obstruction
Turturice, B. A., McGee, H. S., Oliver, B. G. G., Baraket, M., Nguyen, B. T., Ascoli, C., Ranjan, R., Rani, A., Perkins, D. L., & Finn, P. W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184566 · Cited by 36
The Interplay between Host Immunity and Respiratory Viral Infection in Asthma Exacerbation
Hossain, F. M. A., Choi, J., Uyangaa, E., Park, S. O., & Eo, S. K. (2019) · Immune Network · doi:10.4110/in.2019.19.e31 · Cited by 38
“Therefore, the Th17 immune responses can be orchestrated either alone or depending on Th1 or Th2 features, and also reciprocally with Th2 response (103).”
BackgroundBadi, Y. E., Pavel, A. B., Pavlidis, S. P., Riley, J., Bates, S., Kermani, N. Z., Knowles, R. G., Kolmert, J., Wheelock, C. E., Worsley, S. D., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.04.010 · Cited by 38
“The IL-33 receptor (IL1RL1, ST2) was greatly downregulated in the PR group.”
The Immune Mechanisms of Severe Equine Asthma—Current Understanding and What Is Missing
Simões, J., Batista, M., & Tilley, P. (2022) · Animals · doi:10.3390/ani12060744 · Cited by 39
“Contrastingly, considerably less biomarkers are described for the non-Th2 type human asthma, where cytokine profile studies based on genetic, transcriptomic and proteomic analysis are considered fundamental [166,167].”
BackgroundMachado, Y. J., Duinkerken, S., Hoepflinger, V., Mayr, M., Korotchenko, E., Kurtaj, A., Pablos, I., Steiner, M., Stoecklinger, A., Lübbers, J., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.020 · Cited by 33
Hu, M.-B., Liu, Y., Wang, L., Wang, J., Li, L., & Wu, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143553 · Cited by 33
Hu, Q., Jin, L., Zeng, J., Wang, J., Zhong, S., Fan, W., & Liao, W. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1698900 · Cited by 33
Extracellular adenosine 5′-triphosphate in pulmonary disorders
Pelleg, A. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114319 · Cited by 36
Stratification of asthma by lipidomic profiling of induced sputum supernatant
Brandsma, J., Schofield, J. P. R., Yang, X., Strazzeri, F., Barber, C., Goss, V. M., Koster, G., Bakke, P. S., Caruso, M., Chanez, P., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.02.032 · Cited by 34
The influence of asthma on neuroinflammation and neurodevelopment: From epidemiology to basic models
Tamayo, J. M., Osman, H. C., Schwartzer, J. J., & Ashwood, P. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.12.003 · Cited by 36
“The initiation of an allergic asthma response results from an increase in T H 2 cytokines interleukin-4 (IL-4), IL-5, and IL-13, an observation seen in both human patients with asthma and animal models of the disease (Barnes, 2001; Choy et al., 2015).”
Yombo, D. J. K., Mentink‐Kane, M. M., Wilson, M. S., Wynn, T. A., & Madala, S. K. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009145 · Cited by 33
“For intracellular cytokine staining, the cells were stimulated with phorbol 12-myristate 13-acetate (10 ng/ml) and ionomycin (1 g/ml) in the presence of brefeldin A for 3 h as described previously (67).”
MethodSelf-citationTGFβ1 mimetic peptide modulates immune response to grass pollen allergens in mice
Araujo, G. R., Aglas, L., Vaz, E. R., Machado, Y. J., Huber, S., Himly, M., Duschl, A., Goulart, L. R., & Ferreira, F. (2019) · Allergy · doi:10.1111/all.14108 · Cited by 38
Decreased Histone Acetylation Levels at Th1 and Regulatory Loci after Induction of Food Allergy
Alhamwe, B. A., Meulenbroek, L. A. P. M., Veening-Griffioen, D. H., Wehkamp, T., Alhamdan, F., Miethe, S., Harb, H., Hogenkamp, A., Knippels, L. M. J., von Strandmann, E. P., et al. (2020) · Nutrients · doi:10.3390/nu12103193 · Cited by 32
Peripheral airways type 2 inflammation, neutrophilia and microbial dysbiosis in severe asthma
Azim, A., Green, B., Lau, L. C. K., Rupani, H., Jayasekera, N. P., Bruce, K. D., & Howarth, P. H. (2021) · Allergy · doi:10.1111/all.14732 · Cited by 35
Novel Anti-Cytokine Strategies for Prevention and Treatment of Respiratory Allergic Diseases
Gubernatorova, E. O., Namakanova, O. A., Gorshkova, E. A., Medvedovskaya, A. D., Nedospasov, S. A., & Drutskaya, M. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.601842 · Cited by 34
“Th17- and Th2-mediated inflammatory pathways are regulated reciprocally during asthma (8), thus, inhibition of type 2 cytokines, such as IL-4 or IL-5, or administration of corticosteroids leads to reorganization of immune response from Th2-mediated eosinophilic to Th17mediated neutrophilic disease (9, 10).”
BackgroundRecent Advances in Nanomaterials for Asthma Treatment
Xu, Z., Guo, X., Gu, Y., Zheng, H., Zhou, Z., Wang, X., Jiang, S., Wang, G., Xu, C., & Wang, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214427 · Cited by 34
“In recent years, the classification that has attracted attention is mainly based on the types of inflammation and immune cells involved, which can be divided into T helper 2 (Th2)-high and Th2-low subtypes [4,5].”
BackgroundEffects of diesel exhaust particle exposure on a murine model of asthma due to soybean
Álvarez-Simón, D., Muñoz, X., Gómez‐Ollés, S., de Homdedeu, M., Untoria, M.-D., & Cruz, M. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179569 · Cited by 32
“This partial downregulation of the Th2 response may be mediated by the counter regulation mechanism between the Th2 and Th17 pathways described by Choy et al. 2015 [19].”
BackgroundImplications of preexisting asthma on COVID-19 pathogenesis
Ramakrishnan, R. K., Heialy, S. A., & Hamid, Q. A. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00547.2020 · Cited by 35
Metadata
- Authors
- Choy, D. F., Hart, K. M., Borthwick, L. A., Shikotra, A., Nagarkar, D. R., Siddiqui, S., Jia, G., Ohri, C. M., Doran, E., Vannella, K. M., Butler, C. A., Hargadon, B., Sciurba, J. C., Gieseck, R. L., Thompson, R. W., White, S., Abbas, A. R., Jackman, J., Wu, L. C., Egen, J. G., Heaney, L. G., Ramalingam, T. R., Arron, J. R., Wynn, T. A., & Bradding, P.
- Affiliations
- Genentech (US)
- National Institutes of Health (US)
- Newcastle University (GB)
- University of Leicester (GB)
- Queen's University Belfast (GB)
- Corresponding author
- Choy, David F.
- Hart, Kevin M.
- Arron, Joseph R.
- Wynn, Thomas A.
- Bradding, Peter
- ORCID
- Choy, David F.
- Hart, Kevin M.
- Borthwick, Lee A.
- Nagarkar, Deepti R.
- Siddiqui, Salman
- Jia, Guiquan
- Doran, Emma
- Vannella, Kevin M.
- Butler, Claire A.
- Hargadon, Beverley
- Sciurba, Joshua C.
- Gieseck, Richard L.
- Abbas, Alexander R.
- Jackman, Janet
- Egen, Jackson G.
- Heaney, Liam G.
- Ramalingam, Thirumalai R.
- Arron, Joseph R.
- Wynn, Thomas A.
- Bradding, Peter
- Venue
- Science Translational Medicine
- Published
- 2015-08-19
- Volume
- 7
- Issue
- 301
- Pages
- 301ra129-301ra129
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2166997969
- Cited by
- 450
- References
- 63
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 26 · 2023: 34 · 2022: 41 · 2021: 42 · 2020: 71 · 2019: 46 · 2018: 48 · 2017: 46 · 2016: 48 · 2015: 5
- FWCI
- 36.11
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity) (cc-by-nc)
- Funders
- NIH
- NIAID
- Genentech Inc.
- National Institute for Health Research
- Asthma UK (AUK-PG-2013-208)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- asthma, type 2 inflammation, Th17 inflammation, IL-13, IL-17A, IL-4, asthma endotypes, neutrophilic inflammation, eosinophilia, airway hyperresponsiveness, allergic asthma, combination therapy, cytokine neutralization
- MeSH terms
- Animals, Asthma, Cells, Cultured, Female, Humans, Mice, Inbred BALB C, Signal Transduction, Th2 Cells, Interleukin-13, Interleukin-17, Mice, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.